Annual report
3154.TEDINET S100P9B6
Period2021-07-01 → 2022-06-30
Filed2022-09-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100RJV5 (2023-08-14). Amended by S100Z02X (2026-09-03).
Key figures · 154
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥221.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥207.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Revenue | ¥210.4bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥197.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥168.1bn | 2017-07-01 → 2018-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥2.7bn | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2017-07-01 → 2018-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.6bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥951m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥70m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥742m | 2017-07-01 → 2018-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥84.5bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥70.0bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥62.0bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥53.7bn | at 2018-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥68.6bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥15.8bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥13.9bn | at 2020-06-30d | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥10.6bn | at 2018-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.6bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.1bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.8bn | at 2018-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥3.9bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥723m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.8bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥138m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥5.2bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥788m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.66 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.21 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.12 | 2017-07-01 → 2018-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.6 | 2019-07-01 → 2020-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥789.43 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥727.12 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥636.71 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥582.16 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥546.64 | at 2018-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.5% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2018-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.9% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.6% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2017-07-01 → 2018-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,182 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 2,002 | at 2021-06-30 | Cons. | Number of employees |
| Employees | 1,926 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 1,680 | at 2019-06-30d | Cons. | Number of employees |
| Employees | 1,449 | at 2018-06-30d | Cons. | Number of employees |
| Revenue | ¥2.7bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥732m | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥436m | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | ¥998m | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥703m | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥486m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥573m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥424m | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥957m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥687m | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | ¥932m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥663m | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | ¥853m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥614m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥48m | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥23.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥21.5bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥21.5bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.1bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.8bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥15.2bn | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥13.4bn | at 2021-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥8.6bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥8.1bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2020-06-30d | Standalone | Net assets |
| Net assets / equity | ¥6.8bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.5bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥372m | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥460m | at 2021-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥42.56 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.43 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.16 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.16 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.45 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥42.48 | 2021-07-01 → 2022-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.22 | 2020-07-01 → 2021-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.12 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥394.52 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥372.32 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.09 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥310.69 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥283.13 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 36.2% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.8% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.5% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.4% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.9% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.1% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -10.0% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.9% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,925,104 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,453,536 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 71 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 74 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 73 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 66 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 54 | at 2018-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥4.2bn |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥428m |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥39.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥7.5bn |
| Medical Equipment Salesreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥507m |
| Medical Equipment Salesreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥234m |
| Medical Equipment Salesreportable segment | employees | at 2022-06-30 | 1679 pure |
| Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥216.4bn |
| Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥216.4bn |
| Medical Equipment Salesreportable segment | segment assets | at 2022-06-30 | ¥52.1bn |
| Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥9.3bn |
| Nursing Welfarereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥323m |
| Nursing Welfarereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥310m |
| Nursing Welfarereportable segment | employees | at 2022-06-30 | 186 pure |
| Nursing Welfarereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Nursing Welfarereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Nursing Welfarereportable segment | segment assets | at 2022-06-30 | ¥1.1bn |
| Nursing Welfarereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥495m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥830m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥544m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥221.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥221.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥53.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥9.7bn |
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥3.3bn |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥305m |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | ¥38.1bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥6.1bn |
| Medical Equipment Salesreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥391m |
| Medical Equipment Salesreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥161m |
| Medical Equipment Salesreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥202.2bn |
| Medical Equipment Salesreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥202.2bn |
| Medical Equipment Salesreportable segment | segment assets | at 2021-06-30 | ¥45.2bn |
| Medical Equipment Salesreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥8.1bn |
| Nursing Welfarereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥421m |
| Nursing Welfarereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥246m |
| Nursing Welfarereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥5.6bn |
| Nursing Welfarereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥5.6bn |
| Nursing Welfarereportable segment | segment assets | at 2021-06-30 | ¥1.1bn |
| Nursing Welfarereportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥692m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-07-01 → 2021-06-30 | ¥813m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-07-01 → 2021-06-30 | ¥408m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2021-06-30 | ¥207.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2021-06-30 | ¥207.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-06-30 | ¥46.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2021-06-30 | ¥8.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,587
| Item | Context | Value | Unit |
|---|---|---|---|
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E22995-000KuwabaraKazuakiMember | Original text (Japanese)桑原和明 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E22995-000KuwabaraKazuakiMember | 1953-09-17 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E22995-000KuwabaraKazuakiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E22995-000KuwabaraKazuakiMember | Original text (Japanese)(注)４ | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row6Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row7Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | Original text (Japanese)取引先持株会を通じた株式の取得 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)テルモ㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)(保有目的)医療機器調達等における関係維持・強化のため(定量的な保有効果)(注) | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)オリンパス㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)㈱静岡銀行 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)(保有目的)取引関係の維持のため(定量的な保有効果)(注) | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)㈱ハマキョウレックス | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)(保有目的)事業上の関係を強化するため(定量的な保有効果)(注) | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)㈱中京銀行 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)(保有目的)取引関係の維持のため(定量的な保有効果)(注) | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)㈱清水銀行 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)(保有目的)取引関係の維持のため(定量的な保有効果)(注) | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)アルフレッサホールディングス㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)当事業年度中に保有する全株式を売却しました。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)ヤマシタヘルスケアホールディングス㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)当事業年度中に保有する全株式を売却しました。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)無 | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |